Hypoxia in breast cancer: pathogenesis, characterization and biological/therapeutic implications.
about
Inactivation of the CYLD deubiquitinase by HPV E6 mediates hypoxia-induced NF-kappaB activationImaging tumor hypoxia to advance radiation oncologyScanning time-domain optical mammography: detection and characterization of breast tumors in vivo.Exosomal Proteome Profiling: A Potential Multi-Marker Cellular Phenotyping Tool to Characterize Hypoxia-Induced Radiation Resistance in Breast Cancer.Oxygen levels do not determine radiation survival of breast cancer stem cells.The hypoxic microenvironment upgrades stem-like properties of ovarian cancer cells.Hypoxia induces EMT in low and highly aggressive pancreatic tumor cells but only cells with cancer stem cell characteristics acquire pronounced migratory potential.Impact of preoperative anemia on relapse and survival in breast cancer patients.Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER.Effects of exercise training on tumor hypoxia and vascular function in the rodent preclinical orthotopic prostate cancer model.Evaluation of anaemia in patients with multiple myeloma and lymphoma: findings of the European CANCER ANAEMIA SURVEY.A novel role of gap junction connexin46 protein to protect breast tumors from hypoxia.The role of autophagy induced by tumor microenvironment in different cells and stages of cancerCarbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplification.Can erythropoietin therapy improve survival?The impact of anaemia on outcome in cancer.Predicting Responses to Neoadjuvant Chemotherapy in Breast Cancer: ACRIN 6691 Trial of Diffuse Optical Spectroscopic ImagingBeyond anaemia management: evolving role of erythropoietin therapy in neurological disorders, multiple myeloma and tumour hypoxia models.Hypoxia regulates stemness of breast cancer MDA-MB-231 cells.HIF-1α stimulates aromatase expression driven by prostaglandin E2 in breast adipose stroma.HIF2α contributes to antiestrogen resistance via positive bilateral crosstalk with EGFR in breast cancer cells.Primary tumor inflammation in gross tumor volume as a prognostic factor for nasopharyngeal carcinoma patientsThe multifaceted role of autophagy in tumor evasion from immune surveillanceHypoxia, Snail and incomplete epithelial-mesenchymal transition in breast cancer.Modulation of blood flow, hypoxia, and vascular function in orthotopic prostate tumors during exercise.Sensitizing thermochemotherapy with a PARP1-inhibitor.Hypoxia-mediated biological control.Tumour oxygenation: implications for breast cancer prognosis.Hypoxia imaging and radiotherapy: bridging the resolution gap.Inhibition of pH regulation as a therapeutic strategy in hypoxic human breast cancer cells.Exosome: emerging biomarker in breast cancer.Autophagy mediates survival of pancreatic tumour-initiating cells in a hypoxic microenvironment.ATM activation and signaling under hypoxic conditions.[18F]Fluoromisonidazole PET in rectal cancer.Measurements of hypoxia ([(18)F]-FMISO, [(18)F]-EF5) with positron emission tomography (PET) and perfusion using PET ([(15)O]-H(2)O) and power Doppler ultrasonography in feline fibrosarcomas*.Coix lacryma-jobi var. ma-yuen Stapf sprout extract has anti-metastatic activity in colon cancer cells in vitro.The ERβ4 variant induces transformation of the normal breast mammary epithelial cell line MCF-10A; the ERβ variants ERβ2 and ERβ5 increase aggressiveness of TNBC by regulation of hypoxic signaling.The hypoxic tumor microenvironment in vivo selects the cancer stem cell fate of breast cancer cells.F-18 FDG uptake on positron emission tomography as a predictor for lymphovascular invasion in patients with lung adenocarcinoma.Optimizing hemoglobin levels and beyond: strength for living and meaningful survival?
P2860
Q24311308-5D5ACF85-9C4D-4D16-ADB7-F3A6D8192D1CQ27007862-E1ED17DD-D5AC-4BE7-8CFF-0723E398CED3Q33223641-2478C77D-E61D-40CD-AD8D-A47765BB936AQ33644570-7C7855B9-C87A-4D54-8140-B57A3BB6B104Q34222667-A13CC7F4-EDF6-4521-9154-9D453D5A50AEQ34285178-EB9180E3-A180-4FF0-8CF3-978685AB310DQ34438815-8483C3B6-1FE9-4C4E-998B-6FBBDC5458D7Q34565736-20EA0477-BAD6-42BC-9883-B0BE3A0C1B95Q34628919-8ABA6457-D856-4C79-9A2A-39D4873CA3EDQ35029884-A7F717A5-FEE2-42CE-A669-B64F8AAB9012Q35104268-5AA112C6-0E69-4EF7-A3E9-B8B25F35A9C5Q35148391-083F9EF8-EE5D-4BFD-8223-9478E52FF7DFQ35257433-9A9A166D-44DE-4D4B-BFC4-0D310FB09D88Q35835151-23D0E78F-F09C-4C91-982F-1B5312BDF1C6Q35919220-2F71485C-BF56-42DD-83B2-A526748504A1Q36027331-7656B9DF-83EF-478B-92C2-3D2E770745E3Q36104503-8395ED70-87A6-42E2-84D5-F83C4D532D25Q36294794-A8348FE2-E585-4F0E-A1EF-77C00B381972Q36762803-F609B521-F843-494B-B45E-7EA08800A523Q36903378-5EEABFD0-82A7-4DAD-B392-591158BCFA39Q36998209-ACE5AB69-65D6-448B-93E8-6DAB547FF63EQ37046765-82542E29-79A7-40A0-9E57-806046B6FB9CQ37109549-BC0620F4-FFB9-4CCE-BA44-0DEE923DF3DBQ37424052-44887E46-8CF9-460F-9D83-4C9EBB9A594FQ37696695-4CD1D46A-AF69-427E-8903-D558107F556CQ37725418-D06F276E-4045-40D0-952B-AED7C723C224Q37843943-3C5B97FC-DB48-4573-A526-7B987A03692EQ38120823-C14411DE-8780-47F5-8424-F9CE97C46F5BQ38400842-8191C56D-38BE-4141-A1A8-1782F463BD80Q38704678-4D81648A-FE0E-4A3E-B396-56ED4A4F4A8FQ39237769-E269DE75-3EC1-415D-9B0E-2047F38558ACQ39409332-3A1F46A3-2B78-4D3F-9AC4-C8903A4B3367Q39921855-9AB7D21D-1069-49A8-B061-2E8556E3AA2DQ42121596-EA4BEA2D-F808-4DF6-89F0-4F29A24549E2Q43276498-BD4FF6E3-480E-42EE-9BB2-E3D0F8F6C653Q46478867-89018005-CED5-4638-BC73-9C0A0B50747AQ52649598-7ED8B38B-EE76-4A22-9EF8-B2F845E7AB16Q52671376-D243385E-08EB-4020-A624-DDB04BD556AAQ52991183-39F269D4-166B-4EAE-887C-A9B109D97AC2Q54737153-F98D2CBE-E110-4EAA-AE51-7130C4724C2D
P2860
Hypoxia in breast cancer: pathogenesis, characterization and biological/therapeutic implications.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Hypoxia in breast cancer: path ...... ical/therapeutic implications.
@ast
Hypoxia in breast cancer: path ...... ical/therapeutic implications.
@en
Hypoxia in breast cancer: path ...... ical/therapeutic implications.
@nl
type
label
Hypoxia in breast cancer: path ...... ical/therapeutic implications.
@ast
Hypoxia in breast cancer: path ...... ical/therapeutic implications.
@en
Hypoxia in breast cancer: path ...... ical/therapeutic implications.
@nl
prefLabel
Hypoxia in breast cancer: path ...... ical/therapeutic implications.
@ast
Hypoxia in breast cancer: path ...... ical/therapeutic implications.
@en
Hypoxia in breast cancer: path ...... ical/therapeutic implications.
@nl
P2093
P1476
Hypoxia in breast cancer: path ...... ical/therapeutic implications.
@en
P2093
Susanne Briest
P304
P356
10.1046/J.1563-258X.2002.02032.X
P577
2002-01-01T00:00:00Z